Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tanimoto

Showing results (211-220 of 222) with videos related to

Pageof 23
Sort By:
Internal Medicine (Tokyo, Japan)|January 1, 1996
Analysis of 55 transplantations from unrelated volunteer donors facilitated by Tokai Marrow Donor BankY Kodera, Y Morishima, N Hirabayashi, et al.
British Journal of Cancer|October 13, 2006
Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancerN Takigawa, K Kiura, Y Segawa, et al.
Bone Marrow Transplantation|January 18, 2005
Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): results of Japanese phase II studyY Imai, T Chou, K Tobinai, et al.
Leukemia|August 26, 2006
Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrestK Chikamori, J E Hill, D R Grabowski, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 11, 1998
[Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation]N Hirabayashi, S Goto, Y Morishima, et al.
International Journal of Hematology|January 14, 1999
Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of the Japan Adult Leukemia Study Group (JALSG)M Tanimoto, S Miyawaki, T Ino, et al.
International Journal of Hematology|December 10, 1998
Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study GroupT Ueda, S Miyawaki, N Asou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled studyR Ohno, S Miyawaki, K Hatake, et al.
Leukemia Research|August 26, 1998
A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study GroupK Ohnishi, M Tomonaga, N Kamada, et al.
International Journal of Hematology|September 25, 1999
No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study GroupS Miyawaki, M Tanimoto, T Kobayashi, et al.
Pageof 23

Showing results (211-220 of 222) with videos related to

Sort By:
Pageof 23
Internal Medicine (Tokyo, Japan)|January 1, 1996
Analysis of 55 transplantations from unrelated volunteer donors facilitated by Tokai Marrow Donor BankY Kodera, Y Morishima, N Hirabayashi, et al.
British Journal of Cancer|October 13, 2006
Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancerN Takigawa, K Kiura, Y Segawa, et al.
Bone Marrow Transplantation|January 18, 2005
Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): results of Japanese phase II studyY Imai, T Chou, K Tobinai, et al.
Leukemia|August 26, 2006
Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrestK Chikamori, J E Hill, D R Grabowski, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 11, 1998
[Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation]N Hirabayashi, S Goto, Y Morishima, et al.
International Journal of Hematology|January 14, 1999
Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of the Japan Adult Leukemia Study Group (JALSG)M Tanimoto, S Miyawaki, T Ino, et al.
International Journal of Hematology|December 10, 1998
Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study GroupT Ueda, S Miyawaki, N Asou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled studyR Ohno, S Miyawaki, K Hatake, et al.
Leukemia Research|August 26, 1998
A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study GroupK Ohnishi, M Tomonaga, N Kamada, et al.
International Journal of Hematology|September 25, 1999
No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study GroupS Miyawaki, M Tanimoto, T Kobayashi, et al.
Pageof 23